Results 231 to 240 of about 309,378 (343)
Targeting heat shock protein 90 with usnic acid relieves immune suppression via aryl hydrocarbon receptor-mediated mechanisms in lung cancer. [PDF]
Varlı M +5 more
europepmc +1 more source
Inhibition of heat-shock protein 90 reduces Ebola virus replication
Darci R. Smith +7 more
openalex +2 more sources
In vivo evidence for the generation of a glucocorticoid receptor-heat shock protein-90 complex incapable of binding hormone by the calmodulin antagonist phenoxybenzamine. [PDF]
Y. Ning, Estaban Sánchez
openalex +1 more source
Objective Nerve growth factor (NGF), a key mediator of pain, is increased in osteoarthritic (OA) joints. Antibodies against NGF show analgesic effects in painful knee OA, but clinical development was stopped because of side effects in the joints. Knowledge about the biologic effects of NGF on joint tissues is limited. Therefore, we explored the effects
Alia M. Obeidat +14 more
wiley +1 more source
The role of heat shock protein 90 in idiopathic pulmonary fibrosis: state of the art. [PDF]
Monteleone G, Cameli P, Bonella F.
europepmc +1 more source
Heat shock protein 90 (Hsp90) inhibitor STA-9090 (Ganetespib) ameliorates inflammation in a mouse model of atopic dermatitis. [PDF]
Sitko K, Starke M, Tukaj S.
europepmc +1 more source
T cells, the next big target in axSpA?
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease characterized by complex immune dysregulation, with T cells playing a central role in its pathogenesis. In this review we synthesize current knowledge on diverse T cell subsets in axSpA, their pathogenic mechanisms, and emerging therapeutic strategies targeting these cells.
Mansi K. Aparnathi, Nigil Haroon
wiley +1 more source

